Meet the team

Patricio Opazo

"We aim to find ways of boosting the intrinsic synaptic repair mechanisms of the brain, with the ultimate goal of delaying or even preventing the onset of cognitive decline." Patricio Opazo
UK DRI Group Leader

Originally from Chile, Dr Patricio Opazo obtained a PhD at the University of California, Los Angeles in the lab of Dr Thomas O’Dell. Following postdoctoral training in the labs of Dr Daniel Choquet at the Université de Bordeaux and Dr Tobias Bonhoeffer at the Max-Planck Institute of Neurobiology in Munich, he started his own independent group in 2016 in the Queensland Brain Institute (QBI) at The University of Queensland in Brisbane, Australia. In 2021, Dr. Opazo joined the UK DRI in Edinburgh to leverage his long-standing expertise in synaptic plasticity to investigate the synaptic compensatory and repair mechanisms counteracting synaptic loss at the early stages of neurodegeneration.

1. At a glance

Alzheimer’s disease is characterised by the loss of brain connection (synapses) — the main correlate of cognitive deficits — at the early stages in the disease progression. Although much is known about the mechanisms underlying synaptic loss in Alzheimer’s, the repair and compensatory mechanisms within the neuron to counter and compensate for the loss remain largely unexplored.

The overarching aim of Dr Patricio Opazo’s research programme is to understand the cellular and molecular mechanisms underlying synaptic compensation and repair — with the ultimate goal of therapeutically harnessing these inherently protective mechanisms of the brain in order to delay the onset of clinical dementia.

2. Scientific goals

One of the most puzzling aspects of Alzheimer’s disease (AD) is that the accumulation of amyloid and tau pathology precedes the onset of clinical dementia by several decades. Dr Patricio Opazo believes that this delay corresponds to compensatory mechanisms implemented at all levels: first, at the synaptic level following synapse loss, and then at the neuronal and circuit level - and that the saturation of all these compensatory mechanisms mark the onset of clinical dementia.

Given that synaptic plasticity plays a central role in normal cognition as well as in the cognitive deficits associated to AD, Dr Opazo’s research programme aims to determine whether synaptic repair and compensation is critical to tolerate pathology in AD and thus, whether it may serve as the basis for cognitive resilience and future therapeutic opportunities.

Main objectives and research goals:

1. Investigate the synaptic compensatory and repair events triggered by the loss of synapses in Alzheimer’s disease models

2. Identify the molecular mechanisms underlying synaptic compensation and repair using RNA-seq and proteomic approaches

3. Boost synaptic compensatory and repair mechanisms to delay the onset of cognitive decline in Alzheimer’s disease animal models

3. Team members

Calum Bonthron (Postdoctoral Researcher)
Ya Yin Chang (PhD Student, joint with Prof Giles Hardingham)

4. Collaborations

Within UK DRI:

Dr Jenna Gregory (UK DRI at Edinburgh)
Dr Cara Croft (UK DRI at UCL)

Beyond UK DRI:

Dr Daniel Choquet (Université de Bordeaux)
Dr Victor Anggono (University of Queensland)
Prof Colin Smith (University of Edinburgh)

5. Topics

Synaptic plasticity, homeostatic plasticity, synaptic resilience, cognitive reserve, Alzheimer’s disease

6. Techniques

In-vivo and in-vitro two-photon microscopy, optogenetics, in-utero electroporation, AAV injection, behaviour, RNA-seq, proteomics

7. Key publications

Anggono V. and Opazo P., (2022) Editorial: Special issue on The making of memories. Seminars in Cell and Developmental Biology. In press

Choquet, D. and Opazo, P. (2022) The role of AMPAR lateral diffusion in memory. Seminars in Cell and Developmental Biology. In press

Delgado, J.Y., Fink, A.E., Grant, S.G.N., O'Dell, T., and Opazo, P. (2018). Rapid homeostatic downregulation of LTP by extrasynaptic GluN2B receptors. Journal of Neurophysiology, 120 (5), 2351-2357.

Opazo, P., Viana da Silva, S., Carta, M., Breillat, C., Coultrap, S.J., Grillo-Bosch, D.,(2018). CaMKII Metaplasticity Drives Abeta Oligomer-Mediated Synaptotoxicity. Cell Rep 23, 3137-3145.

Hafner, A.S., Penn, A.C., Grillo-Bosch, D., Retailleau, N., Poujol, C., Philippat, A., . . Opazo., P* and Choquet, D*. (2015). Lengthening of the Stargazin Cytoplasmic Tail Increases Synaptic Transmission by Promoting Interaction to Deeper Domains of PSD-95. Neuron 86, 475-489. *Co-last and co-corresponding.

Opazo, P., Labrecque, S., Tigaret, C.M., Frouin, A., Wiseman, P.W., De Koninck, P., and Choquet, D. (2010). CaMKII triggers the diffusional trapping of surface AMPARs through phosphorylation of stargazin. Neuron 67, 239-252

8. Lab website

Follow Patricio on Twitter
Connect wtih Patricio on LinkedIn

Founding funders

Latest tweets from @UKDRI

What role will AI have in the future of healthcare? Prof Caleb Webber, UK DRI Director of Informatics, believes we… https://t.co/osuj336b1Y
04 Oct 2022 08:38

RT @Cara_Croft: If you are at @autophagyuk annual conference then be sure to stop by @DaviVontobel's poster showcasing some of the work he'…
04 Oct 2022 08:11